In our latest eBook, we hear from researchers and key opinion leaders in pathology about the unmet needs in bladder and prostate cancer diagnostics – and how to address them.
What are the implications of skipping prostate cancer screening tests? How might DNA methylation testing address unmet needs in bladder cancer surveillance? Why should pathologists be the stewards of all molecular testing? How can biomarker testing for prostate cancer be optimized?
The answers to these questions and more can be found by downloading the eBook below!
